Literature DB >> 26323418

Dosage Form Developments of Nanosuspension Drug Delivery System for Oral Administration Route.

Ang Chen, Ye Shi, Zhiqiang Yan, Hongxun Hao, Yong Zhang, Jian Zhong, Huiming Hou1.   

Abstract

A large amount of new drug candidates are practically insoluble in aqueous solvents and are even simultaneously poorly soluble in organic solvents. Nanosuspension drug delivery system (DDS) was firstly developed in 1994 and has attracted more and more attention as a formation solution for the poorly soluble drugs. By nansizing the poorly soluble drugs, nanosuspensions have several outstanding advantages for drug delivery. Among many administration routes of drug delivery, oral administration is the most preferred route due to its advantages such as ease of ingestion, versatility to accommodate various types of drug candidates, low production cost, high safety, good patient compliance, and pain avoidance. Current marketed pharmaceutical nanosuspension DDS products are mostly for oral administration. This review is to systematically summarize the nanosuspension DDS dosage form developments of poorly soluble drugs for oral administration use.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26323418     DOI: 10.2174/1381612821666150901105026

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  5 in total

Review 1.  Recent Advances in Oral Nano-Antibiotics for Bacterial Infection Therapy.

Authors:  Ze-Liang Wu; Jun Zhao; Rong Xu
Journal:  Int J Nanomedicine       Date:  2020-12-01

2.  Preparation, Characterization, and Evaluation of Breviscapine Nanosuspension and Its Freeze-Dried Powder.

Authors:  Ting Zhang; Xixi Li; Juewen Xu; Jingbao Shao; Meihong Ding; Senlin Shi
Journal:  Pharmaceutics       Date:  2022-04-24       Impact factor: 6.525

3.  Design and Solidification of Fast-Releasing Clofazimine Nanoparticles for Treatment of Cryptosporidiosis.

Authors:  Yingyue Zhang; Jie Feng; Simon A McManus; Hoang D Lu; Kurt D Ristroph; Eugene J Cho; Ellen L Dobrijevic; Hak-Kim Chan; Robert K Prud'homme
Journal:  Mol Pharm       Date:  2017-09-20       Impact factor: 4.939

Review 4.  Nanoparticles for antiparasitic drug delivery.

Authors:  Yuzhu Sun; Dongmei Chen; Yuanhu Pan; Wei Qu; Haihong Hao; Xu Wang; Zhenli Liu; Shuyu Xie
Journal:  Drug Deliv       Date:  2019-12       Impact factor: 6.419

5.  Dasatinib Nanoemulsion and Nanocrystal for Enhanced Oral Drug Delivery.

Authors:  Chuanqi Wang; Manting Wang; Peng Chen; Jiexin Wang; Yuan Le
Journal:  Pharmaceutics       Date:  2022-01-15       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.